Antithrombin activity of lepirudin adsorbed to silicone (polydimethylsiloxane) tubing

Thrombosis Research

Volumn 112, Issue 1-2, 2003, Pages 111-115

  Horne III, McDonald K ^a   Brokaw, Kimberly J ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Lepirudin; Polydimethylsiloxane; Silicone; Venous catheters

Indexed keywords

ANTICOAGULANT AGENT; ARGATROBAN; DESULFATOHIRUDIN; DIMETICONE; LEPIRUDIN; POLYMER; THROMBIN;

ADSORPTION; ANTICOAGULATION; ARTICLE; CATHETER; DRUG ACTIVITY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SILASTIC TUBE; THROMBOGENICITY; THROMBOSIS;

EID: 0842303027     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.10.009     Document Type: Article

References (16)

1. Horne M.K., Mayo D.J., Freifeld A.G. The use of venous access devices. Beutler E., Coller B.S., Lichtman M.A., Kipps T.J., Seligsohn U. Williams hematology. 6th ed. 2001;257-259 McGraw-Hill, New York.
2. Peters W.R., Bush W.H., McIntyre R.D., Hill L.D. The development of fibrin sheath on indwelling venous catheters. Surg. Gynecol. Obstet. 137:1973;43-47.
3. Horne M.K., Mayo D.J., Alexander H.R., Steinhaus E.P., Whitman E.D., Chang R.et al. Venographic surveillance of tunneled venous access devices in adult oncology patients. Ann. Surg. Oncol. 2:1995;174-178.
4. Elam J.H., Nygren H. Adsorption of coagulation proteins from whole blood on to polymer materials: relation to platelet activation. Biomaterials. 13:1992;3-8.
5. Keuren J.F.W., Wielders S.J.H., Willems G.M., Morra M., Lindhout T. Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood. Thromb. Haemost. 87:2002;742-747.
6. Francis C.W., Felcher A.H., White J., Braaten J.V., Goss R. Thrombin activity associated with indwelling central venous catheters. Thromb. Haemost. 77:1997;48-52.
7. Klement P., Du Y.J., Berry L., Andrew M., Chan A.K.C. Blood-compatible biomaterials by surface coating with a novel antithrombin-heparin covalent complex. Biomaterials. 23:2002;527-535.
8. Larm O., Larsson R., Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomater. Med. Dev. Artif. Organs. 11:1983;161-173.
9. Hursting M.J., Alford K.L., Becker J.-C.P., Brooks R.L., Joffrion J.L., Knappenberger G.D.et al. Novastan™ (brand of argatroban): a small-molecule, direct thrombin inhibitor. Semin. Thromb. Hemost. 23:1997;503-516.
10. Nowak G. Pharmacology of recombinant hirudin. Semin. Thromb. Hemost. 28:2002;415-423.
11. Seifert B., Romaniuk P., Groth T. Covalent immobilization of hirudin improves the haemocompatibility of polylactide-polyglycolide in vitro. Biomaterials. 18:1997;1495-1502.
12. Rydel T.J., Ravichandran K.G., Tulinsky A., Bode W., Huber R., Roitsch C.et al. The structure of a complex of recombinant hirudin and human α-thrombin. Science. 249:1990;277-280.
13. Chuang H.Y.K., Andrade J.D. Immunochemical detection by specific antibody to thrombin of prothrombin conformational changes upon adsorption to artificial surfaces. J. Biomed. Mater. Res. 19:1985;813-825.
14. Lindon J.N., McManama G., Kushner L., Merrill E.W., Salzman E.W. Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces? Blood. 68:1986;355-362.
15. Laster J., Silver D. Heparin-coated catheters and heparin-induced thrombocytopenia. J. Vasc. Surg. 7:1988;667-672.
16. Fenton J.W., Fasco M.J., Stackrow A.B., Aronson D.L., Yound A.M., Finlayson J.S. Human thrombins: production, evaluation, and properties of α-thrombin. J. Biol. Chem. 252:1977;3587-3598.